|
Status |
Public on Jun 26, 2023 |
Title |
TMPRSS2-ERG and gain-of-function p53 mutants co-dictate pyrimidine synthesis and prostate cancer fitness |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Sep 22, 2021 |
Last update date |
Jun 29, 2023 |
Contact name |
LIGUO WANG |
E-mail(s) |
wang.liguo@mayo.edu
|
Organization name |
Mayo Clinic
|
Department |
Division of Computational Biology
|
Street address |
200 1st St SW
|
City |
Rochester |
State/province |
MN |
ZIP/Postal code |
55905 |
Country |
USA |
|
|
Platforms (2) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
Samples (28)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE184623 |
TMPRSS2-ERG and gain-of-function p53 mutants co-dictate pyrimidine synthesis and prostate cancer fitness [ERG and p53 ChIP-seq] |
GSE184624 |
TMPRSS2-ERG and gain-of-function p53 mutants co-dictate pyrimidine synthesis and prostate cancer fitness [RNA-seq-2018 ERG-p53 project] |
GSE184625 |
TMPRSS2-ERG and gain-of-function p53 mutants co-dictate pyrimidine synthesis and prostate cancer fitness [RNA-seq-2021 ERG-p53 project] |
|
Relations |
BioProject |
PRJNA765377 |